Abstract
The epidermal skin barrier plays an important role in protecting underlying structures. It allows the passage of low molecular weight lipophilic molecules, but restricts the passage of hydrophilic molecules and macromolecules. The objective of this study was to investigate the feasibility of transdermal delivery of human growth hormone (hGH) through laser-microporated dermatomed porcine ear skin. The permeation of hGH was evaluated at different laser fluences and micropore densities. In vitro permeation studies were performed on vertical Franz diffusion cells using dermatomed porcine ear skin treated with ablative laser (2940 nm; P.L.E.A.S.E®, Pantec Biosolutions AG). The effect of different fluences (34.1, 45.4, and 68.1 J/cm2) at 10% pore density as well as different densities of micropores (5, 10, and 15%) at fluence of 34.1 J/cm2, on the permeation of hGH was evaluated. After 48 h, 77.12 ± 10.77 μg/cm2 hGH was delivered into the receptor with the application of fluence of 45.4 J/cm2, which was significantly higher than that observed from 34.1 J/cm2 group (53.13 ± 1.75 μg/cm2, p < 0.05). Application of fluence of 68.1 J/cm2 showed permeation of 90.94 ± 3.93 μg/cm2 that was significantly higher than that from 34.1 J/cm2 group (p < 0.05), but not as compared to the 45.4 J/cm2 group (p > 0.05). With the increase in density of micropores from 5 to 15%, permeation of hGH increased significantly from 7.1 ± 2.63 μg/cm2 to 95.89 ± 13.43 μg/cm2 after 48 h (p < 0.05). Thus, overall, the variations in the fluence as well as micropore density of the laser were observed to influence hGH permeation, through laser-microporated dermatomed porcine skin.
Similar content being viewed by others
Abbreviations
- ANOVA:
-
Analysis of variance
- ELISA:
-
Enzyme-linked immunosorbent assay
- hGH:
-
Human growth hormone
- P.L.E.A.S.E®:
-
Precise Laser Epidermal System
References
Strobl JS, Thomas MJ. Human growth hormone. Pharmacol Rev. 1994;46:1–34.
Cai Y, Xu M, Yuan M, Liu Z, Yuan W. Developments in human growth hormone preparations: sustained-release, prolonged half-life, novel injection devices, and alternative delivery routes. Int J Nanomedicine. 2014;9:3527–38.
Rogol AD. Growth hormone and the adolescent athlete: what are the data for its safety and efficacy as an ergogenic agent? Growth Hormon IGF Res. 2009;19:294–9.
Bartke A. Growth hormone and aging: a challenging controversy. Clin Interv Aging. 2008;3:659–65.
Takano K, Shizume K, Hibi I. A comparison of subcutaneous and intramuscular administration of human growth hormone (hGH) and increased growth rate by daily injection of hGH in GH deficient children. Endocrinol Jpn. 1988;35:477–84.
Levin G, Gershonowitz A, Sacks H, Stern M, Sherman A, Rudaev S, et al. Transdermal delivery of human growth hormone through RF-microchannels. Pharm Res. 2005;22:550–5.
Banga AK. Transdermal and intradermal delivery of therapeutic agents: application of physical technologies: CRC Press; 2011.
Pubchem. Human growth hormone (32–38) | C39H60N8O13 - PubChem [Internet]. [cited 2017]. Available from: https://pubchem.ncbi.nlm.nih.gov/compound/126658
Hessenberger M, Weiss R, Weinberger EE, Boehler C, Thalhamer J, Scheiblhofer S. Transcutaneous delivery of CpG-adjuvanted allergen via laser-generated micropores. Vaccine. 2013;31:3427–34.
Terhorst D, Fossum E, Baranska A, Tamoutounour S, Malosse C, Garbani M, et al. Laser-assisted intradermal delivery of adjuvant-free vaccines targeting XCR1+ dendritic cells induces potent antitumoral responses. J Immunol. 2015;194:5895–902.
Weiss R, Hessenberger M, Kitzmüller S, Bach D, Weinberger EE, Krautgartner WD, et al. Transcutaneous vaccination via laser microporation. J Control Release. 2012;162:391–9.
Ganti SS, Banga AK. Non-ablative fractional laser to facilitate transdermal delivery. J Pharm Sci. 2016;105:3324–32.
Lee W-R, Shen S-C, Al-Suwayeh SA, Yang H-H, Yuan C-Y, Fang J-Y. Laser-assisted topical drug delivery by using a low-fluence fractional laser: imiquimod and macromolecules. J Control Release. 2011;153:240–8.
Brunner M, Dehghanyar P, Seigfried B, Martin W, Menke G, Müller M. Favourable dermal penetration of diclofenac after administration to the skin using a novel spray gel formulation. Br J Clin Pharmacol. 2005;60:573–7.
Miyatake S, Ichiyama H, Kondo E, Yasuda K. Randomized clinical comparisons of diclofenac concentration in the soft tissues and blood plasma between topical and oral applications. Br J Clin Pharmacol. 2009;67:125–9.
Lee W-R, Shen S-C, Liu C-R, Fang C-L, Hu C-H, Fang J-Y. Erbium:YAG laser-mediated oligonucleotide and DNA delivery via the skin: an animal study. J Control Release. 2006;115:344–53.
Gómez C, Costela Á, García-Moreno I, Llanes F, Teijón JM, Blanco MD. Skin laser treatments enhancing transdermal delivery of ALA. J Pharm Sci. 2011;100:223–31.
Bachhav YG, Summer S, Heinrich A, Bragagna T, Böhler C, Kalia YN. Effect of controlled laser microporation on drug transport kinetics into and across the skin. J Control Release. 2010;146:31–6.
Bach D, Weiss R, Hessenberger M, Kitzmueller S, Weinberger EE, Krautgartner WD, et al. Transcutaneous immunotherapy via laser-generated micropores efficiently alleviates allergic asthma in Phl p 5–sensitized mice. Allergy. 2012;67:1365–74.
Chen X, Shah D, Kositratna G, Manstein D, Anderson RR, Wu MX. Facilitation of transcutaneous drug delivery and vaccine immunization by a safe laser technology. J Control Release. 2012;159:43–51.
Nguyen HX, Banga AK. Enhanced skin delivery of vismodegib by microneedle treatment. Drug Deliv Transl Res. 2015;5:407–23.
Sachdeva V, Zhou Y, Banga AK. In vivo transdermal delivery of leuprolide using microneedles and iontophoresis. Curr Pharm Biotechnol. 2013;14:180–93.
Puri A, Nguyen HX, Banga AK. Microneedle-mediated intradermal delivery of epigallocatechin-3-gallate. Int J Cosmet Sci. 2016;38:512–23.
Davies DJ, Ward RJ, Heylings JR. Multi-species assessment of electrical resistance as a skin integrity marker for in vitro percutaneous absorption studies. Toxicol Vitro. 2004;18:351–8.
Shaji J, Varkey D. Recent advances in physical approaches for transdermal penetration enhancement. Curr Drug Ther. 2012;7:184–97.
Ruan R, Chen M, Zou L, Wei P, Liu J, Ding W, et al. Recent advances in peptides for enhancing transdermal macromolecular drug delivery. Ther Deliv. 2016;7:89–100.
Bachhav YG, Heinrich A, Kalia YN. Controlled intra- and transdermal protein delivery using a minimally invasive Erbium:YAG fractional laser ablation technology. Eur J Pharm Biopharm. 2013;84:355–64.
Oni G, Brown SA, Kenkel JM. Can fractional lasers enhance transdermal absorption of topical lidocaine in an in vivo animal model? Lasers Surg Med. 2012;44:168–74.
Bachhav YG, Heinrich A, Kalia YN. Using laser microporation to improve transdermal delivery of diclofenac: increasing bioavailability and the range of therapeutic applications. Eur J Pharm Biopharm. 2011;78:408–14.
Dick IP, Scott RC. Pig ear skin as an in-vitro model for human skin permeability. J Pharm Pharmacol. 1992;44:640–5.
Jacobi U, Kaiser M, Toll R, Mangelsdorf S, Audring H, Otberg N, et al. Porcine ear skin: an in vitro model for human skin. Skin Res Technol. 2007;13:19–24.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interests
The authors declare that they have no conflict of interest.
Rights and permissions
About this article
Cite this article
Song, Y., Hemmady, K., Puri, A. et al. Transdermal delivery of human growth hormone via laser-generated micropores. Drug Deliv. and Transl. Res. 8, 450–460 (2018). https://doi.org/10.1007/s13346-017-0370-y
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13346-017-0370-y